Skip to main content

Table 2 Cases of chronic infection

From: An international, multicentre evaluation and description of Burkholderia pseudomallei infection in cystic fibrosis

Patient

Duration of infection

Year of acquisition

Eradication attempted

Eradication successful

Outcome

1 (O’Carroll, 2003) [12]

>15 years

1987

No

N/A

Slow decline in lung health consistent with CF; transplant 2004

10 (O’Carroll, 2003) [12]

11 years

2001

No

N/A

Slow decline in lung health consistent with CF

3 (Schülin, 2001) [14]

>9 years

1992

Yes

No

Increased frequency of exacerbations

15

>8 years

2005

Yes

No

Accelerated decline; transplant declined due to B. pseudomallei infection; B. pseudomallei septicaemia;a died 2009

22 (Radhakrishna, 2014) [17]

7 years

2011

Yes

Yes

No obvious clinical impact

2

7 years

Early 1990’s

No

N/A

Spontaneously clearance of infection after approx. 7 years; 11 years later died of neutropenic sepsis complicating treatment of Duke’s C colon cancer.

7 (Holland, 2002) [16]

>6 years

2000

Yes

No

Accelerated decline with increased frequency of exacerbations; B. pseudomallei septicaemia; died 2009

17

6 years

2007

No

N/A

Slow decline in lung health consistent with CF

18

6 years

2007

Yes

No

Accelerated decline; transplant declined due to B. pseudomallei; died 2013

11 (Holland, 2002) [15]

5 years

2001

Yes

No

Accelerated decline; transplant 2006; died 2011

23

>12 months

2012

Yes

No

Progressive destruction right upper lobe

6 (Holland, 2002) [16]

>4 years

1999

Yes

No

After presumed latency of 4 years developed accelerated decline with pneumonia; died 2004

24

4 years

2009

Yes

Unknown

Fall in lung function; stable after targeted antimicrobial therapy

14 (Barth, 2007) [9]

>2 years

2005

Yes

No

Accelerated decline with rapid decrease in lung function and recurrent exacerbations over 2 years; long term outcome unknown

8 (O’Carroll, 2003) [12]

2 years

2000

Yes

No

Rapid decline post infection; died 2 years after initial infection

21

2 years

2010

Yes

No

Accelerated decline; transplant 2012 with persistent infection post-transplant

12 (O’Carroll, 2003) [12]

2 years

2001

Yes

Yes

Repeated admissions with pneumonia, treated with 3 week courses of ceftazidime, meropenem, tobramycin; infection ultimately spontaneously cleared

4 (Visca, 2001) [15]

1 year

1998

Yes

Yes

Deteriorating pulmonary sepsis, increasingly refractory to anti-pseudomonal antibiotics; cleared infection with antimicrobial therapy; still alive 2013

13 (Asiah, 2006) [8]

1 year

2004

Yes

Yes

Increased pulmonary sepsis during infection with B. pseudomallei; remained well 5 months after completing targeted anti-microbial therapy

  1. aRecurrent episodes of B. pseudomallei bacteremia
  2. bIn patient 5 the duration of infection and long term outcome was unknown